Compare DEI & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DEI | TWST |
|---|---|---|
| Founded | 1971 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2006 | 2018 |
| Metric | DEI | TWST |
|---|---|---|
| Price | $10.47 | $42.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 9 |
| Target Price | $14.79 | ★ $47.89 |
| AVG Volume (30 Days) | ★ 2.6M | 1.3M |
| Earning Date | 02-10-2026 | 02-02-2026 |
| Dividend Yield | ★ 7.22% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $1,000,336,000.00 | $376,572,000.00 |
| Revenue This Year | $2.82 | $16.77 |
| Revenue Next Year | $1.47 | $15.06 |
| P/E Ratio | $84.47 | ★ N/A |
| Revenue Growth | 3.61 | ★ 20.32 |
| 52 Week Low | $10.46 | $23.30 |
| 52 Week High | $18.61 | $54.74 |
| Indicator | DEI | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 30.41 | 65.39 |
| Support Level | $10.71 | $39.13 |
| Resistance Level | $10.83 | $43.34 |
| Average True Range (ATR) | 0.25 | 2.34 |
| MACD | -0.03 | 0.17 |
| Stochastic Oscillator | 5.52 | 69.61 |
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.